Results 1 to 10 of about 1,473 (162)
Furazolidone-based therapies for Helicobacter pylori infection: A pooled-data analysis
The Saudi Journal of Gastroenterology, 2012 Background/Aim: Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed ...
Angelo Zullo +3 more
doaj +2 more sources
Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy. [PDF]
PLoS ONE, 2013 BACKGROUND: Calreticulin is a Ca(2+)-binding chaperone of the endoplasmic reticulum which regulates the signal transducer and activator of transcription 3 (STAT3). The effects of the calreticulin-STAT3 signaling pathway on cardiac mitochondria and on the
Ming Zhang +7 more
doaj +2 more sources
Comparison of Furazolidone Versus Clarithromycin for Eradication of Helicobacter Pylori Infection: A Randomized Multicenter Clinical Trial [PDF]
Afro-Egyptian Journal of Infectious and Endemic Diseases, 2021 Background and study aims: to evaluate efficacy of Furazolidone versus clarithromycin in quadruple therapy for eradication of Helicobacter Pylori (HP) infection . Patients and Method: During a period of six months, all of the cases with HP infection
Maryam Lajmirnia +5 more
doaj +1 more source
BMJ Open, 2020 Objectives Furazolidone containing regimen is effectivefor Helicobacter pylori (H. pylori) infection, but its safetyremains controversial. To assess the safety of furazolidone containing regimenin H.
Jing Liu +6 more
doaj +1 more source
Risk factors of furazolidone-associated fever.
PLoS ONE, 2022 BackgroundFurazolidone is a synthetic nitrofuran with a broad spectrum of antimicrobial action and has been widely used in the treatment of Helicobacter pylori (H. pylori) infection. However, its safety profile has not been clarified.
Jiali Zhang +6 more
doaj +1 more source
Frontiers in Microbiology, 2022 BackgroundThe increasing antimicrobial resistance of Helicobacter pylori (H. pylori) has resulted in a fall in cure rates. We aimed to assess the effectiveness of first-line susceptibility-guided therapy and furazolidone-based quadruple therapy for H ...
Peiwei Li +5 more
doaj +1 more source
Терапевтический архив, 2023 Background. First-line therapy does not always provide a high level of Helicobacter pylori eradication due to the increase of H. pylori resistance to antibiotics; therefore, it remains necessary to identify the most effective rescue treatments.
Dmitry S. Bordin +25 more
doaj +1 more source
Фармация и фармакология (Пятигорск), 2022 Taking into account the current Product specification file, the aim of the work was to develop the composition and technology for obtaining effervescent tablets based on solid dispersions of furazolidone in the form of an aqueous solution for external ...
A. O. Elagina +10 more
doaj +1 more source
BMC Veterinary Research, 2022 Background Trueperella pyogenes and Pseudomonas aeruginosa are two important bacterial pathogens closely relating to the occurrence and development of forest musk deer respiratory purulent disease. Although T.
Qin Chen +8 more
doaj +1 more source
Microorganisms, 2023 Helicobacter pylori is a pathogen related to severe diseases such as gastric cancer; because of rising antimicrobial-resistant strains, failure to eradicate H. pylori with antibiotics has increased worldwide. Multidrug-resistant H.
Ayush Khangai +7 more
doaj +1 more source